These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 33073653)

  • 1. Nonpharmacological Management of Diabetic Foot Ulcers: An Update.
    Eleftheriadou I; Samakidou G; Tentolouris A; Papanas N; Tentolouris N
    Int J Low Extrem Wounds; 2021 Sep; 20(3):188-197. PubMed ID: 33073653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on management of diabetic foot ulcers.
    Everett E; Mathioudakis N
    Ann N Y Acad Sci; 2018 Jan; 1411(1):153-165. PubMed ID: 29377202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis and treatment of impaired wound healing in diabetes mellitus: new insights.
    Baltzis D; Eleftheriadou I; Veves A
    Adv Ther; 2014 Aug; 31(8):817-36. PubMed ID: 25069580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic Foot Ulcers: A Review of Debridement Techniques.
    Sa BC; Maskan Bermudez N; Shimon SV; Kirsner RS
    Surg Technol Int; 2024 Jul; 44():31-35. PubMed ID: 38372560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
    Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
    Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative pressure wound therapy, artificial skin and autogenous skin implantation in diabetic foot ulcers.
    Chia-Jui H; Yu L; Jiang YQ; Tan W; Gao GM; Li HB; Han L
    J Wound Care; 2022 Jan; 31(1):40-46. PubMed ID: 35077212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancing pharmacotherapy for diabetic foot ulcers.
    Eleftheriadou I; Tentolouris A; Tentolouris N; Papanas N
    Expert Opin Pharmacother; 2019 Jun; 20(9):1153-1160. PubMed ID: 30958725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Meta-Analysis of the Outcomes of Metatarsal Head Resection for the Treatment of Neuropathic Diabetic Foot Ulcers.
    Yammine K; Kheir N; Assi C
    Adv Wound Care (New Rochelle); 2021 Feb; 10(2):81-90. PubMed ID: 32870773
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of CXCL8 in chronic nonhealing diabetic foot ulcers and phenotypic changes in fibroblasts: a molecular perspective.
    Rai V; Moellmer R; Agrawal DK
    Mol Biol Rep; 2022 Feb; 49(2):1565-1572. PubMed ID: 35044539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary wound closure of diabetic foot ulcers by debridement and stitching.
    Ahmed ME; Mohammed MS; Mahadi SI
    J Wound Care; 2016 Nov; 25(11):650-654. PubMed ID: 27827282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic foot ulcer: an evidence-based treatment update.
    Braun LR; Fisk WA; Lev-Tov H; Kirsner RS; Isseroff RR
    Am J Clin Dermatol; 2014 Jul; 15(3):267-81. PubMed ID: 24902659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular versus acellular matrix devices in treatment of diabetic foot ulcers: study protocol for a comparative efficacy randomized controlled trial.
    Lev-Tov H; Li CS; Dahle S; Isseroff RR
    Trials; 2013 Jan; 14():8. PubMed ID: 23298410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Therapeutic Modalities for the Management of Chronic Diabetic Wounds of the Foot.
    Oyebode OA; Jere SW; Houreld NN
    J Diabetes Res; 2023; 2023():1359537. PubMed ID: 36818748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in Dermoepidermal Skin Substitutes for Diabetic Foot Ulcers.
    Álvaro-Afonso FJ; García-Álvarez Y; Lázaro-Martínez JL; Kakagia D; Papanas N
    Curr Vasc Pharmacol; 2020; 18(2):182-192. PubMed ID: 30963977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired dermal microvascular reactivity and implications for diabetic wound formation and healing: an evidence review.
    O'Brien TD
    J Wound Care; 2020 Sep; 29(Sup9):S21-S28. PubMed ID: 32924808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Multinational, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy of Cyclical Topical Wound Oxygen (TWO2) Therapy in the Treatment of Chronic Diabetic Foot Ulcers: The TWO2 Study.
    Frykberg RG; Franks PJ; Edmonds M; Brantley JN; Téot L; Wild T; Garoufalis MG; Lee AM; Thompson JA; Reach G; Dove CR; Lachgar K; Grotemeyer D; Renton SC;
    Diabetes Care; 2020 Mar; 43(3):616-624. PubMed ID: 31619393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical gel-based biomaterials for the treatment of diabetic foot ulcers.
    Bardill JR; Laughter MR; Stager M; Liechty KW; Krebs MD; Zgheib C
    Acta Biomater; 2022 Jan; 138():73-91. PubMed ID: 34728428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic foot ulcers: evaluation and management.
    Maderal AD; Vivas AC; Zwick TG; Kirsner RS
    Hosp Pract (1995); 2012 Aug; 40(3):102-15. PubMed ID: 23086099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous fat grafting combined with negative pressure wound therapy in severe diabetic foot ulcer: a case study.
    Biyao Z; Gang X; Hai J; Chenwang D; Xuan L
    J Wound Care; 2021 Apr; 30(Sup4):S38-S40. PubMed ID: 33856926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of debridement and Vacuum-Assisted Closure (V.A.C.) Therapy in diabetic foot ulcers.
    Eneroth M; van Houtum WH
    Diabetes Metab Res Rev; 2008; 24 Suppl 1():S76-80. PubMed ID: 18393328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.